## ACNB: ACNB Corporation - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.12 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-4.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($45.22)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 14 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 30.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- FMR, LLC: 5.8% (0.0%)
- Blackrock Inc.: 5.8% (-1.4%)
- Vanguard Group Inc: 5.1% (-1.9%)
- Private Capital Mana: 3.3% (+9.9%)
- Dimensional Fund Adv: 3.0% (+2.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.12 suggests fair value with growth premium. Forward P/E 9.5x stretched relative to 2% growth. Quality metrics strong (margin 24%). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $0.5B |
| Beta | 0.86 |
| 52W Range | $35.70 - $51.44 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.12 |
| Forward P/E | 9.5 |
| Current P/E | 9.7 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 4.5% to 0.1% (-4.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.9pp (needs >4.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.08% (CS: 52) | Neutral |
| RSI_14 | 56.2 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.055x | Above |
| vs SMA200 | 1.109x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $47.92
- **Stop Loss:** $45.22 (5.6% risk)
- **Target:** $53.32 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 370
- **Position Value:** $17,730.40
- **Portfolio %:** 17.73%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-22 (Est: $1.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.18 | $1.44 | +21.7% |
| 2025Q2 | $1.15 | $1.25 | +8.8% |
| 2025Q1 | $0.93 | $0.79 | -15.0% |
| 2024Q4 | $0.85 | $0.86 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*